Core Viewpoint - The announcement details the results of the 2025 restricted stock incentive plan of Shanghai Xiaofang Pharmaceutical Co., Ltd., including the number of shares granted and the conditions surrounding the stock awards [2][3]. Group 1: Restricted Stock Grant Details - The registration date for the reserved grant of restricted stock is February 2, 2026 [2]. - A total of 260,033 shares were granted to 23 eligible participants after 7 participants voluntarily forfeited 59,967 shares [3][5]. - The grant price for the restricted stock is set at 12.77 yuan per share [5]. Group 2: Incentive Plan Conditions - The effective period of the restricted stock is up to 36 months from the completion of the registration [6]. - The lock-up period for the granted restricted stock is 12 to 24 months, during which the stock cannot be transferred or used as collateral [7]. Group 3: Financial Aspects - The total funds received from the 23 participants amount to 3,320,621.41 yuan, with 260,033 yuan allocated to share capital and the remainder to capital reserves [9]. - The company plans to use the funds raised from this incentive plan to supplement its working capital [12]. Group 4: Impact on Shareholding Structure - The completion of the restricted stock registration will not lead to any changes in the company's controlling shareholder or actual controller [11].
上海小方制药股份有限公司关于2025年限制性股票激励计划预留授予结果公告